Results 191 to 200 of about 29,988 (285)

Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth

open access: gold, 2016
Alexa R. Weingarden   +7 more
openalex   +2 more sources

Microbiome‐Informed Dosing: Exploring Gut Microbial Communities Impact on Mycophenolate Enterohepatic Circulation and Therapeutic Target Achievement

open access: yesClinical Pharmacology &Therapeutics, Volume 118, Issue 6, Page 1477-1488, December 2025.
Pharmacomicrobiomics is an emerging field due to important microbiome effects on pharmacokinetics and clinical outcomes. However, the application of this knowledge remains limited. Mycophenolic acid (MPA) is the primary active metabolite of the immunosuppressant, mycophenolate mofetil (MMF).
Abdelrahman Saqr   +4 more
wiley   +1 more source

Knowledge and Acceptability of Fecal Microbiota Transplantation Among Patients, Caregivers, and Health Care Providers in Ethiopia. [PDF]

open access: yesOpen Forum Infect Dis
Shackelford BB   +9 more
europepmc   +1 more source

Pharmacomicrobiomics

open access: yesClinical Pharmacology &Therapeutics, Volume 118, Issue 6, Page 1366-1377, December 2025.
Oral medications encounter gut commensal microbes that participate directly and indirectly in drug effects through metabolism, interactions with drug metabolites, or production of substrates that compete with drugs for drug‐metabolizing enzymes, consequently influencing drug pharmacokinetics.
Naomi Gronich   +11 more
wiley   +1 more source

A Fast Path from Innovation to Safe and Effective Medicines

open access: yesClinical Pharmacology &Therapeutics, Volume 118, Issue 6, Page 1392-1404, December 2025.
Consistent progress in medicines development has allowed both for de novo treatment options and for the refinement of existing products that improve effectiveness or reduce harm. Nonetheless, unmet medical needs persist, particularly in rare diseases, pediatrics and underserved populations.
Peter Arlett   +11 more
wiley   +1 more source

Butyrate‐Mediated Upregulation of Insulin Pathway Gene Expression Suggests Potential Antidiabetic Effects

open access: yesDrug Development Research, Volume 86, Issue 8, December 2025.
ABSTRACT Type 2 diabetes (T2D) is a major cause of morbidity in developed countries and involves insulin resistance, a failure to correctly respond to insulin. Numerous studies in rodent T2D models suggested that the short‐chain fatty acid butyrate, produced by gut microbiota species through fermentation of dietary fibers, improves T2D symptoms.
Elad Shapira   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy